label int64 1 1 | id stringlengths 10 12 | original_id stringlengths 8 9 | text stringlengths 347 29.5k |
|---|---|---|---|
1 | 171770263_b0 | 171770263 | 442 6,148 6,839 6,747 29,877 26,176 19,784
Operating loss
(9,609) (7,845) (7,378) (7,245) (6,870) (6,658) (6,871) (6,772) (32,077) (27,171) (21,705)
Total other expense
(182) (221) (216) (382) (359) (404) (432) (397) (1,001) (1,592) (2,836)
Net loss
$ (9,791) $ (8,066) $ (7,594) $ (7,627)
$ (7,229)
$ (7,062) $ ... |
1 | 171770263_b1 | 171770263 | ited) (Details) -
USD ($) $ / shares in Units, $ in
Thousands
3 Months Ended
12 Months Ended
Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31, Dec. 31, Dec. 31, 2016 2016 2016 2016 2015 2015 2015 2015 2016 2015 2014
Quarterly Financial Information
Disclosure [Abstract]
Revenue
$ 53... |
1 | 171773086_0 | 171773086 | Innocoll Holdings Plc
Form 10-K
Filed on 16-Mar-2017 Period 31-Dec-2016 Accession number: 0001571049-17-002507
Included Items
1. 10-K: FORM 10-K 2. EX-21.1: EXHIBIT 21.1 3. EX-23.1: EXHIBIT 23.1 4. EX-31: EXHIBIT 31.1 5. EX-31: EXHIBIT 31.2 6. EX-32.1: EXHIBIT 32.1
UNITED STATES SECURITIES AND EXCHANGECOMMISSION
Wa... |
1 | 171773086_1 | 171773086 | name of registrant as specified in its charter)
Ireland (State or other jurisdiction of incorporation or organization)
N/A (I.R.S. Employer Identification No.)
Unit 9, Block D Monksland Business Park
Monksland, Athlone Ireland
(Address of principal executive offices)
N/A (Zip Code)
Registrant's telephone number, ... |
1 | 171773086_2 | 171773086 | filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No ¨
Indicate by chec... |
1 | 171773086_3 | 171773086 | smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
¨ Large Accelerated Filer
x Accelerated Filer
¨ Non-Accelerated Filer
¨ Smaller Reporting Company
Indicate by check mark whether the regi... |
1 | 171773086_b0 | 171773086 | , as of the end of the period covered by this report based on such evaluation and
(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report... |
1 | 171773086_b1 | 171773086 | respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report
4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e... |
1 | 171781388_0 | 171781388 | SPARK NETWORKS INC
Form 10-K
Filed on 22-Mar-2017 Period 31-Dec-2016 Accession number: 0001564590-17-004940
Included Items
1. 10-K 2. EX-10.5 3. EX-21.1 4. EX-23.1 5. EX-31.1 6. EX-31.2 7. EX-32.1 8. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
ANNUAL REPORT PUR... |
1 | 171781388_1 | 171781388 |
(State or other jurisdiction of incorporation or organization)
20-8901733
(I.R.S. Employer Identification No.)
11150 Santa Monica Boulevard, Suite 600, Los Angeles, California
(Address of principal executive offices)
90025
(Zip Code)
REGISTRANT'S TELEPHONENUMBER, INCLUDING AREACODE: (310) 893-0550
SECURITIES REGI... |
1 | 171781388_2 | 171781388 | rant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 duringthe preceding12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filingrequirements for the past 90 days. Yes No
Indicate b... |
1 | 171781388_3 | 171781388 | . See definitions of "accelerated filer," "large accelerated filer" and "smaller reportingcompany" in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reportingcompany
Indicate by check mark whether the registrant is a shell company (as de... |
1 | 171781388_b0 | 171781388 | ,211 2,053
Amortization of intangible assets
69 68 78 78 78 10 10 10 293 108 40
Impairment of intangible and long-lived assets
4,480 58
52
39
65 26 37 69
4,629 197 128
Total cost and expenses
11,769 8,632 9,238 13,341 11,954 12,300 12,419 12,560 42,980 49,233 62,583
Operating loss
(4,026) (241) (140) (3,482... |
1 | 171781388_b1 | 171781388 | of revenue (exclusive of depreciation shown separately below)
1,647
2,323
2,653
6,229
5,017 5,593 6,368 7,097
12,852 24,075 34,321
Sales and marketing
854 1,103 1,380 1,452 1,242 1,144 996 755 4,789 4,137 5,127
Customer service
545 523 840 993 826 769 721 749 2,901 3,065 3,038
Technical operations
350 419 ... |
1 | 171782259_0 | 171782259 | Yandex N.V.
Form 20-F
Filed on 22-Mar-2017 Period 31-Dec-2016 Accession number: 0001513845-17-000004
Included Items
1. 20-F 2. EX-1.2 3. EX-8.1 4. EX-12.1 5. EX-12.2 6. EX-13.1 7. EX-15.1 8. XBRL (render)
TABLE OF CONTENTS YANDEX N.V. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents
(Mark One)
UNI... |
1 | 171782259_1 | 171782259 | ANTTOSECTION 13 OR 15(d) OFTHESECURITIESEXCHANGEACTOF1934 For the transitionperiodfrom to OR
SHELLCOMPANYPURSUANTTOSECTION 13 OR 15(d) OFTHESECURITIESEXCHANGEACTOF1934 Date of event requiring this shell companyreport
Commission file number: 001-35173
YANDEX N.V.
(Exact name of Registrant as specified in its charter) N/... |
1 | 171782259_2 | 171782259 | the Act.
Title of each class
Class A Ordinary Shares
Name of each exchange on which registered
NASDAQ Global Select Market
Securities registered or to be registered pursuant to Section 12(g) of the Act. None Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act. Class A Ordinary S... |
1 | 171782259_3 | 171782259 | those Sections.
Indicate by checkmarkwhether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such f... |
1 | 171782259_b0 | 171782259 | Long-lived assets, net:
Total long-lived assets, net 11.3
1,109
1,002
684
Rest of the world
Revenues:
Total revenues
104.0
RUB 6,306 5,104
4,525
Rest of the world
Long-lived assets, net:
Total long-lived assets, net $ 14.2
RUB 1,071 RUB 1,723 RUB 862
RELATED-PARTY TRANSACTIONS (Details) RUB in Millions,... |
1 | 171782259_b1 | 171782259 | ues by Geography Dec. 31, 2016 Dec. 31, 2016 Dec. 31, 2015 Dec. 31, 2014 Dec. 31, 2016
(Details)
USD ($)
RUB
RUB
RUB
RUB
RUB in Millions, $ in Millions
Revenues:
Total revenues
$ 1,251.7 RUB 75,925 RUB 59,792 RUB 50,767
Long-lived assets, net:
Total long-lived assets, net 566.6
36,931
30,321
RUB 34,372
... |
1 | 171782306_0 | 171782306 | Ascendis Pharma A/S
Form 20-F
Filed on 22-Mar-2017 Period 31-Dec-2016 Accession number: 0001193125-17-092073
Included Items
1. 20-F: FORM 20-F 2. EX-8.1 3. EX-12.1 4. EX-12.2 5. EX-13.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 20-F
(Mark One)
REGISTRATION STA... |
1 | 171782306_1 | 171782306 | ) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
Commission file number: 001-36815
Ascendis Pharma A/S
(Exact name of Registrant as specified in its charter and translation of Registrant's name into English)
The Kingdom of Denmark
(Jurisdiction of incorporation or organizati... |
1 | 171782306_2 | 171782306 | for trading, but only in connection with the registration of the American Depositary Shares. Securities registered or to be registered pursuant to Section 12(g) of the Act: None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
Indicate the number of outstanding shares of... |
1 | 171782306_3 | 171782306 | such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and
posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the ... |
1 | 171782306_b0 | 171782306 | change in the Company's internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting and
5. The Company's other certifying officer and I have dis... |
1 | 171782306_b1 | 171782306 | periods presented in this report
4. The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a 15(f) and 1... |
1 | 171782376_0 | 171782376 | ENI SPA
Form 20-F
Filed on 22-Mar-2017 Period 31-Dec-2016 Accession number: 0001174947-17-000442
Included Items
1. 20-F: FORM 20-F 2. EX-1: EXHIBIT 1 3. EX-8: EXHIBIT 8 4. EX-11: EXHIBIT 11 5. EX-12.1: EXHIBIT 12.1 6. EX-12.2: EXHIBIT 12.2 7. EX-13.1: EXHIBIT 13.1 8. EX-13.2: EXHIBIT 13.2 9. EX-99.15AI: EXHIBIT 15A.(... |
1 | 171782376_1 | 171782376 | SECTION 12(b) or (g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2016
OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ... |
1 | 171782376_2 | 171782376 | 52041765
(Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title ofeach class
Shares
American Depositary Shares
(Which represent the right to receive two Shares)
Name ofeach exchange on wh... |
1 | 171782376_3 | 171782376 | the Securities Act.
Yes
No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Yes
No
Note - Checking the box above will not relieve any registrant required to file r... |
1 | 171782376_b0 | 171782376 | type" if drilled in a known area. (31) Undeveloped oil and gas reserves. Undeveloped oil and gas reserves are reserves of any category that are expected to be recovered from new wells on undrilled acreage, or from existing wells where a relatively major expenditure is required for recompletion. (i) Reserves on undrill... |
1 | 171782376_b1 | 171782376 | and permeable underground formation containing a natural accumulation of producible oil and/or gas that is confined by impermeable rock or water barriers and is individual and separate from other reservoirs.(28) Resources. Resources are quantities of oil and gas estimated to exist in naturally occurring accumulations.... |
1 | 171782478_0 | 171782478 | DBV Technologies S.A.
Form 20-F
Filed on 22-Mar-2017 Period 31-Dec-2016 Accession number: 0001193125-17-092134
Included Items
1. 20-F 2. EX-4.12 3. EX-4.13 4. EX-4.14 5. EX-8.1 6. EX-12.1 7. EX-12.2 8. EX-13.1 9. EX-13.2 10. EX-15.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C... |
1 | 171782478_1 | 171782478 |
For the transition period from
to
OR
SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report
Commission File Number 001-36697
DBV TECHNOLOGIES S.A.
(Exact name of registrant as specified in its charter and translation of regis... |
1 | 171782478_2 | 171782478 | nominal value 0.10 per share
Ordinary shares, nominal value 0.10 per share*
Name of each exchange on which registered
The Nasdaq Stock Market LLC
The Nasdaq Stock Market LLC*
* Not for trading, but only in connection with the registration of the American Depositary Shares. Securities registered or to be registered p... |
1 | 171782478_3 | 171782478 | ) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by c... |
1 | 171782478_b0 | 171782478 | ) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 22, 2017
/s/ Pierre-Henr... |
1 | 171782478_b1 | 171782478 | likely to adversely
affect the company's ability to record, process, summarize and report financial information and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company's internal control over financial
reporting.
Date: March 22, 2017
/s/ D... |
1 | 171785428_0 | 171785428 | Cellectis S.A.
Form 20-F
Filed on 23-Mar-2017 Period 31-Dec-2016 Accession number: 0001193125-17-093898
Included Items
1. 20-F 2. EX-8.1 3. EX-12.1 4. EX-12.2 5. EX-13.1 6. EX-13.2 7. EX-15.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
(Mark One)
REGISTRAT... |
1 | 171785428_1 | 171785428 | EXCHANGE ACT OF 1934
Commission file number 001-36891
CELLECTIS S.A.
(Exact name of Registrant as specified in its charter and translation of Registrant's name into English)
France
(Jurisdiction of incorporation or organization)
Cellectis S.A. 8, rue de la Croix Jarry
75013 Paris, France
(Address of principal execut... |
1 | 171785428_2 | 171785428 |
Name of each exchange on which registered
Nasdaq Global Market
Nasdaq Global Market*
Securities registered or to be registered pursuant to Section 12(g) of the Act.
None
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.
None
Indicate the number of outstanding shares of ea... |
1 | 171785428_3 | 171785428 | 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Da... |
1 | 171785428_b0 | 171785428 | Exchange Commission or its staff upon request.
EXHIBIT 13.2
Certification by the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Cellectis S.A. (the "Company") on Form 20-F for the fiscal year... |
1 | 171785428_b1 | 171785428 | 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Cellectis S.A. (the "Company") on Form 20-F for the fiscal year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, André C... |
1 | 171787344_0 | 171787344 | Nabriva Therapeutics AG
Form 10-K
Filed on 24-Mar-2017 Period 31-Dec-2016 Accession number: 0001104659-17-019162
Included Items
1. 10-K 2. EX-21 3. EX-23.1 4. EX-31.1 5. EX-31.2 6. EX-32.1 7. EX-32.2 8. XBRL (render)
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-... |
1 | 171787344_1 | 171787344 | Republic of Austria (State or jurisdiction of organization)
Not applicable (I.R.S. Employer Identification No.)
Leberstrasse 20 1110 Vienna, Austria (Address of principal executive offices)
Not applicable (Zip Code)
43 (0)1 740 930 (Registrant's telephone number, including area code)
Securities registered pursuant... |
1 | 171787344_2 | 171787344 | ) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically an... |
1 | 171787344_3 | 171787344 | filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer o
Accelerated filer o
Non-accelerated filer x (Do not check if a smaller reporting company)
Smaller reporting company o
Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the... |
1 | 171787344_b0 | 171787344 | , Sep. 30, Jun. 30, Mar. 31, Dec. 31, Sep. 30, Jun. 30, Mar. 31, Dec. 31, Dec. 31, Dec. 31, 2016 2016 2016 2016 2015 2015 2015 2015 2016 2015 2014
$ 2,307 $ 971 $ 1,785 $ 1,419 $ 974 $ 1,297 $ 899 $ 597 $ 6,482 $ 3,767 $ 2,398
(17,047) (15,050) (13,311) (16,121) (11,215) (9,624) (6,420) (4,266) (61,529) (31,525) (13,... |
1 | 171787344_b1 | 171787344 |
6,241
19,679
Total
57,926
$ 40,972
Contingencies
Contingent liabilities
$ 0
12 Months Ended
Related Parties (Details) $ in Thousands
Dec. 31, 2016 USD ($)
Dec. 31, 2015 USD ($)
Dec. 31, 2014 USD ($)
Mar. 31, 2015 USD ($) agreement
Convertible Loan Agreements
Related Parties
Aggregate principal amount
... |
1 | 171792656_0 | 171792656 | AVADEL PHARMACEUTICALS PLC
Form 10-K
Filed on 28-Mar-2017 Period 31-Dec-2016 Accession number: 0001012477-17-000021
Included Items
1. 10-K: FORM 10-K 2. EX-4.1: EXHIBIT 4.1 3. EX-10.31: EXHIBIT 10.31 4. EX-10.32: EXHIBIT 10.32 5. EX-21.1: EXHIBIT 21.1 6. EX-23.1: EXHIBIT 23.1 7. EX-23.2: EXHIBIT 23.2 8. EX-31.1: EXHI... |
1 | 171792656_1 | 171792656 | URSUANTTO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACTOF 1934 For the fiscal year ended December 31, 2016
Commission file number: 000-28508
AVADEL PHARMACEUTICALS PLC
(Exact name of registrant as specified in its charter)
Ireland State or other jurisdiction of incorporation or organization
98-1341933 (I.R.S. Emp... |
1 | 171792656_2 | 171792656 | share. Not for trading, but only in connection with the listing of American Depositary Shares.
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ¨ No ý
Indicate by check mark if t... |
1 | 171792656_3 | 171792656 | to submit and post such files). Yes ý No ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated b... |
1 | 171792656_b0 | 171792656 |
Number of securities called by warrants (in shares)
3,300,000
3,300,000 3,300,000
Percentage of earn out payment
20.00% 20.00%
Affiliated Entity | Deerfield CSF LLC
Related Party Transaction [Line Items]
Percentage of royalty payable on net sales
1.75%
Affiliated Entity | Deerfield CSF LLC | FSC
Related Part... |
1 | 171792656_b1 | 171792656 | Transaction [Line
Items]
Payments to acquire businesses, gross
$ 30,838
$ 27,897
$ 11,936
Percentage of royalty payable on net sales
0.834%
Deerfield Debt Financing
Related Party Transaction [Line
Items]
Repayments of long-term lines of credit
$ 15,000
Broadfin Debt Financing
Related Party Transaction [L... |
1 | 171795227_0 | 171795227 | Presbia PLC
Form 10-K
Filed on 29-Mar-2017 Period 31-Dec-2016 Accession number: 0001564590-17-005529
Included Items
1. 10-K: 10K 2. EX-21.1 3. EX-23.1 4. EX-31.1 5. EX-31.2 6. EX-32.1 7. XBRL (render)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
(Mark One)
ANNUAL REPORT PURSU... |
1 | 171795227_1 | 171795227 |
120/121 Baggot Street Lower Dublin 2 Ireland
(Address of principal executive offices, including zip code)
Registrant's Telephone Number, Including Area Code: +353 (1) 659 9446
98-1162329
(IRS Employer Identification No.)
Securities registered pursuant to Section 12(b) of the Act:
Ordinary Shares, $0.001 Par Value
(... |
1 | 171795227_2 | 171795227 | reports), and (2) has been subject to such filingrequirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (... |
1 | 171795227_3 | 171795227 | Non-accelerated filer
Accelerated filer
Smaller reportingcompany
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No
The aggregate market value of the Registrant's ordinary shares (the only common equity of the Registrant) held by non-affil... |
1 | 171795227_b0 | 171795227 | compensation (11)
241
Deferred tax assets
4,628
3,340
Valuation allowance
(4,559) (3,247)
Net deferred tax assets
69
93
Deferred tax liabilities:
Depreciation
(69)
(93)
Total deferred tax liabilities $ (69)
$ (93)
Income Taxes - Additional Information (Detail) - USD ($)
Income Tax [Line Items] Operati... |
1 | 171795227_b1 | 171795227 | Effective
Rate (Detail)
12 Months Ended Dec. 31, 2016 Dec. 31, 2015
Income Tax Disclosure [Abstract]
Expected income tax benefit at federal statutory rate 35.00% 35.00%
State tax provision, net of federal benefit
0.00%
0.00%
Foreign rate differential
(25.00%) (25.00%)
Pass-through entities
(0.00%) (0.00%)
C... |
1 | 171797440_0 | 171797440 | Voxeljet AG
Form 20-F
Filed on 30-Mar-2017 Period 31-Dec-2016 Accession number: 0001558370-17-002306
Included Items
1. 20-F 2. EX-8.1 3. EX-12.1 4. EX-12.2 5. EX-13.1 6. EX-13.2
Table of Contents
As filedwiththe Securities andExchange CommissiononMarch30, 2017
UNITED STATES
SECURITIES AND EXCHANGECOMMISSION
WASH... |
1 | 171797440_1 | 171797440 | F1934
OR
SHELLCOMPANYREPORTPURSUANTTOSECTION13OR15(d) OFTHESECURITIESEXCHANGEACTOF1934
Commission file number 001 36130
voxeljet AG
(Exact name ofRegistrant as specified in its charter)
Not Applicable (Translation ofRegistrant's name into English)
Federal Republic of Germany (Jurisdiction ofincorporation or organi... |
1 | 171797440_2 | 171797440 | Name of each exchange on which registered New YorkStockExchange LLC New YorkStockExchange LLC*
* Not for trading purposes, but only in connection with the registration ofAmerican Depositary Shares pursuant to the requirements ofthe Securities and Exchange Commission.
Securities registered or to be registered pursuant... |
1 | 171797440_3 | 171797440 | be filed by Section 13 or 15(d) ofthe Securities Exchange Act of1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has... |
1 | 171797440_b0 | 171797440 |
/s/ RUDOLF FRANZ Rudolf Franz Chief Financial Officer (Principal Financial Officer)
Dated: March 30, 2017
Exhibit 13.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANESOXLEY ACT OF 2002
In connection with the Annual Report on Form 20F of v... |
1 | 171797440_b1 | 171797440 | rant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation and
(d) Disclosed in this report any change in the registrant's internal control over fin... |
1 | 171801019_0 | 171801019 | SEQUANS COMMUNICATIONS
Form 20-F
Filed on 31-Mar-2017 Period 31-Dec-2016 Accession number: 0001383395-17-000003
Included Items
1. 20-F: 20-F SEQUANS COMMUNICATIONS 2016
2. EX-1.1: EXHIBIT 1.1 3. EX-8.1: EXHIBIT 8.1 4. EX-12.1: EXHIBIT 12.1 5. EX-12.2: EXHIBIT 12.2 6. EX-13.1: EXHIBIT 13.1 7. EX-13.2: EXHIBIT 13.2 8. ... |
1 | 171801019_1 | 171801019 | ) OF THESECURITIES EXCHANGEACT OF 1934
For the fiscal year ended December 31, 2016
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
For the transition period from
to
OR
¨
SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
Date of... |
1 | 171801019_2 | 171801019 | 16 09
(Name, telephone, e-mail and/or facsimile number and address of company contact person)
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class
American Depositary Shares, each representing one ordinary share, nominal value 0.02 per share Ordinary shares, nominal val... |
1 | 171801019_3 | 171801019 | a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ¨ Yes þ No
If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Yes ¨ No þ
Indicate by check mark w... |
1 | 171801019_b0 | 171801019 | to the BSA (Warrants) Issuance Agreements dated (2) January 11, 2011 and March 8, 2011 of Sequans Communications S.A.,
Registration Statement (Form S-8 No. 333-187611) pertaining to the Stock Option Subscription Plan, BSA Subscription (3) Plan and BSA (Warrants) Issuance Agreements dated June 26, 2012 of Sequans Commu... |
1 | 171801019_b1 | 171801019 | , 2016 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Deborah Choate, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) The Report fully complies with ... |
1 | 171801397_0 | 171801397 | Akari Therapeutics Plc
Form 20-F
Filed on 31-Mar-2017 Period 31-Dec-2016 Accession number: 0001144204-17-018167
Included Items
1. 20-F: FORM 20-F 2. EX-10.12: EXHIBIT 10.12 3. EX-10.13: EXHIBIT 10.13 4. EX-10.15: EXHIBIT 10.15 5. EX-10.17: EXHIBIT 10.17 6. EX-21.1: EXHIBIT 21.1 7. EX-23.1: EXHIBIT 23.1 8. EX-23.2: EX... |
1 | 171801397_1 | 171801397 |
(Mark One)
FORM 20-F
¨
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THESECURITIES EXCHANGEACT OF 1934
OR
x
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
For the fiscal year ended December 31, 2016
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE... |
1 | 171801397_2 | 171801397 | Kingdom
(Address of principal executive offices)
Gur Roshwalb Chief Executive Officer 75/76 Wimpole Street
LondonW1G 9RT United Kingdom Telephone +44 20 8004 0270 (Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)
Securities registered or to be registered pursuant to Section 12(b... |
1 | 171801397_3 | 171801397 | of American Depositary Shares representing such Ordinary Shares pursuant to the requirements of the Securities and Exchange Commission.
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
¨ Yes x No
If this report is an annual or transition report,... |
1 | 171801397_b0 | 171801397 | 14
Total operating loss carry forwards
38,399,914
Foreign Tax Authority [Member]
Operating Loss Carryforwards [Line Items]
2017
0
2018
0
2019
0
2020
0
2021
0
Beyond 2021
21,785,348
Total operating loss carry forwards
$ 21,785,348
Taxes (Details Textual) USD ($)
12 Months Ended Dec. 31, 2016 Dec. 31... |
1 | 171801397_b1 | 171801397 |
15,596
0
Tax rate difference in foreign jurisdictions
2,341,113 (1,964,914) (153,415)
Income tax expense
$ 0
$ 0
$ 0
Taxes (Details 3) - USD ($) Dec. 31, 2016 Dec. 31, 2015
Deferred tax assets
Stock-based compensation
$ 994,618 $ 210,573
Stock option and warrant revaluation 1,525,594 3,181,481
Tax loss c... |
1 | 171802300_0 | 171802300 | Proqr Therapeutics N.V.
Form 20-F
Filed on 31-Mar-2017 Period 31-Dec-2016 Accession number: 0001193125-17-106844
Included Items
1. 20-F 2. EX-1.1 3. EX-4.12 4. EX-4.13 5. EX-4.14 6. EX-8.1 7. EX-12.1 8. EX-12.2 9. EX-13.1 10. EX-15.1
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.... |
1 | 171802300_1 | 171802300 | ACT OF 1934
OR
SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of event requiring this shell company report: Not applicable
For the transition period from
to
Commission file number 001-36622
PROQR THERAPEUTICS N.V.
(Exact name of Registrant as specified in its ch... |
1 | 171802300_2 | 171802300 | be registered pursuant to Section 12(g) of the Act: None
(Title of Class)
Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None
(Title of Class)
Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period... |
1 | 171802300_3 | 171802300 | the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No
Indicate by check mark whether the registrant has submitted electronically and post... |
1 | 171802300_b0 | 171802300 | have a significant role in the Company's internal control over financial reporting.
Date: March 31, 2017
By: /S/ Smital Shah Name: Smital Shah Title: Chief Financial Officer (Principal Financial Officer)
Exhibit 13.1
Certification by the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Secti... |
1 | 171802300_b1 | 171802300 | financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting princip... |
1 | 171805334_0 | 171805334 | EDAP TMS SA
Form 20-F
Filed on 03-Apr-2017 Period 31-Dec-2016 Accession number: 0001171843-17-001921
Included Items
1. 20-F: FORM 20-F 2. EX-1.1: EXHIBIT 1.1 3. EX-8.1: EXHIBIT 8.1 4. EX-11.1: EXHIBIT 11.1 5. EX-12.1: EXHIBIT 12.1 6. EX-12.2: EXHIBIT 12.2 7. EX-13.1: EXHIBIT 13.1 8. EX-15.1: EXHIBIT 15.1 9. XBRL (ren... |
1 | 171805334_1 | 171805334 | THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016
OR
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ________ to _________
OR
Shell Company Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act o... |
1 | 171805334_2 | 171805334 | , France (Name, Telephone, E-mail and Address of Company Contact Person) Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class American Depositary Shares, each representing
One Ordinary Share Ordinary Shares, nominal value 0.13 per share
Name of each exchange on which reg... |
1 | 171805334_3 | 171805334 | 1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12
months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No
Indicate by ... |
1 | 171805334_b0 | 171805334 |
Note 27 - Valuation Accounts - Schedule of Valuation
Accounts (Details) - EUR () in Thousands
12 Months Ended Dec. 31, 2016 Dec. 31, 2015
Allowance for Deferred Tax Assets [Member]
Balance
19,212 23,125
Charges to costs and expenses
238
218
Deductions: write-off and others
(4,131)
Balance
19,450
19,21... |
1 | 171805334_b1 | 171805334 | operating income (loss) Total Assets Capital expenditures Long-lived assets Goodwill FDA [Member] Sales of goods Sales of RPPs & leases Sales of spare parts and services Total sales Other revenues Total revenues Total COS Gross margin Research and development expenses Selling and marketing expenses
(7,560) 742 24,202... |
1 | 171813284_0 | 171813284 | BP PLC
Form 20-F
Filed on 06-Apr-2017 Period 31-Dec-2016 Accession number: 0001193125-17-112384
Included Items
1. 20-F 2. EX-7 3. EX-12 4. EX-13 5. EX-15.1 6. EX-15.2
Table of Contents
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 20-F
(Mark One)
REGISTRATION STATEMENT PURSUANT TO... |
1 | 171813284_1 | 171813284 | .l.c.
(Exact name of Registrant as specified in its charter)
England and Wales
(Jurisdiction of incorporation or organization)
1 St James's Square, London SW1Y4PD United Kingdom
(Address of principal executive offices)
Dr Brian Gilvary BP p.l.c.
1 St James's Square, London SW1Y4PD United Kingdom
Tel +44 (0) 20 7496 53... |
1 | 171813284_2 | 171813284 | 241% Guaranteed Notes due 2018 4.750% Guaranteed Notes due 2019 2.237% Guaranteed Notes due 2019 1.676% Guaranteed Notes due 2019 2.315% Guaranteed Notes due 2020 2.521% Guaranteed Notes due 2020 4.500% Guaranteed Notes due 2020
Name of each exchange on which registered
NewYork Stock Exchange* NewYork Stock Exchange N... |
1 | 171813284_3 | 171813284 | % Guaranteed Notes due 2024 3.506% Guaranteed Notes due 2025 3.119% Guaranteed Notes due 2026 3.017% Guaranteed Notes due 2027 3.588% Guaranteed Notes due 2027 3.723% Guaranteed Notes due 2028
NewYork Stock Exchange NewYork Stock Exchange NewYork Stock Exchange NewYork Stock Exchange NewYork Stock Exchange NewYork Sto... |
1 | 171813284_b0 | 171813284 | of any such governmental actions which would restrict the recovery of the December 31, 2016, estimated oil and gas volumes.
DEGOLYER AND MACNAUGHTON
15
DeGolyer and MacNaughton is an independent petroleum engineering consulting firm that has been providing petroleum consulting services throughout the world since 1... |
1 | 171813284_b1 | 171813284 | which was held constant for the life of the property. For the PSA holdings in Vietnam, ROSNEFT has represented that sales gas is priced according to terms of a Gas Sales Agreement and that the average price is U.S.$2.93 per Mcf.
DEGOLYER AND MACNAUGHTON
14
Expenses and Costs
Current expenses and costs, and forecas... |
1 | 171815589_0 | 171815589 | Globant S.A.
Form 20-F
Filed on 07-Apr-2017 Period 31-Dec-2016 Accession number: 0001144204-17-019512
Included Items
1. 20-F 2. EX-8.1: EXHIBIT 8.1 3. EX-12.1: EXHIBIT 12.1 4. EX-12.2: EXHIBIT 12.2 5. EX-13.1: EXHIBIT 13.1 6. EX-13.2: EXHIBIT 13.2 7. EX-15.1: EXHIBIT 15.1
UNITED STATES SECURITIES AND EXCHANGECOMMIS... |
1 | 171815589_1 | 171815589 | ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
OR
¨ SHELL COMPANYREPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGEACT OF 1934
Date of event requiring this shell company report
For the transition period from
to
.
Commission file number: 001-36535
GLOBANT S... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.